
<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns="http://www.w3.org/TR/REC-html40">


<head>
<meta name=Title content="">
<meta name=Keywords content="">
<meta http-equiv=Content-Type content="text/html; charset=unicode">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 14">
<meta name=Originator content="Microsoft Word 14">
<link rel=File-List href="cv-content_files/filelist.xml">
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Shahla Young</o:Author>
  <o:LastAuthor>Shahla Young</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>0</o:TotalTime>
  <o:Created>2012-07-24T21:14:00Z</o:Created>
  <o:LastSaved>2012-07-24T21:14:00Z</o:LastSaved>
  <o:Pages>7</o:Pages>
  <o:Words>4964</o:Words>
  <o:Characters>28299</o:Characters>
  <o:Lines>235</o:Lines>
  <o:Paragraphs>66</o:Paragraphs>
  <o:CharactersWithSpaces>33197</o:CharactersWithSpaces>
  <o:Version>14.0</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=themeData href="cv-content_files/themedata.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:TrackMoves/>
  <w:TrackFormatting/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-US</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:SplitPgBreakAndParaMark/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="&#45;-"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
  DefSemiHidden="true" DefQFormat="false" DefPriority="99"
  LatentStyleCount="276">
  <w:LsdException Locked="false" Priority="0" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Normal"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 1"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 2"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 3"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 4"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 5"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 6"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 7"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 8"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 9"/>
  <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" Priority="10" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Title"/>
  <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" Priority="11" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>
  <w:LsdException Locked="false" Priority="22" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" Priority="20" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" Priority="59" SemiHidden="false"
   UnhideWhenUsed="false" Name="Table Grid"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--p.P5
	{min-height: 18.0px;}

 /* Font Definitions */
@font-face
	{font-family:Times;
	panose-1:2 0 5 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"ＭＳ 明朝";
	mso-font-charset:78;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1791491579 18 0 131231 0;}
@font-face
	{font-family:"ＭＳ 明朝";
	mso-font-charset:78;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1791491579 18 0 131231 0;}
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Times;
	mso-fareast-font-family:"ＭＳ 明朝";
	mso-fareast-theme-font:minor-fareast;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.p1, li.p1, div.p1
	{mso-style-name:p1;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:14.5pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"ＭＳ 明朝";
	mso-fareast-theme-font:minor-fareast;}
p.p2, li.p2, div.p2
	{mso-style-name:p2;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"ＭＳ 明朝";
	mso-fareast-theme-font:minor-fareast;}
p.p3, li.p3, div.p3
	{mso-style-name:p3;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"ＭＳ 明朝";
	mso-fareast-theme-font:minor-fareast;}
p.p4, li.p4, div.p4
	{mso-style-name:p4;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.25in;
	margin-bottom:.0001pt;
	text-indent:-2.25in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"ＭＳ 明朝";
	mso-fareast-theme-font:minor-fareast;}
p.p5, li.p5, div.p5
	{mso-style-name:p5;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"ＭＳ 明朝";
	mso-fareast-theme-font:minor-fareast;}
p.p6, li.p6, div.p6
	{mso-style-name:p6;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"ＭＳ 明朝";
	mso-fareast-theme-font:minor-fareast;}
p.p7, li.p7, div.p7
	{mso-style-name:p7;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"ＭＳ 明朝";
	mso-fareast-theme-font:minor-fareast;}
p.p8, li.p8, div.p8
	{mso-style-name:p8;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.25in;
	margin-bottom:.0001pt;
	text-indent:-1.0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"ＭＳ 明朝";
	mso-fareast-theme-font:minor-fareast;}
p.p9, li.p9, div.p9
	{mso-style-name:p9;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:99.0pt;
	margin-bottom:.0001pt;
	text-indent:-81.0pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"ＭＳ 明朝";
	mso-fareast-theme-font:minor-fareast;}
p.p10, li.p10, div.p10
	{mso-style-name:p10;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"ＭＳ 明朝";
	mso-fareast-theme-font:minor-fareast;}
p.p11, li.p11, div.p11
	{mso-style-name:p11;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	text-indent:-31.5pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"ＭＳ 明朝";
	mso-fareast-theme-font:minor-fareast;}
p.p12, li.p12, div.p12
	{mso-style-name:p12;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-indent:-31.5pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"ＭＳ 明朝";
	mso-fareast-theme-font:minor-fareast;}
p.p13, li.p13, div.p13
	{mso-style-name:p13;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	text-indent:-31.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"ＭＳ 明朝";
	mso-fareast-theme-font:minor-fareast;}
p.p14, li.p14, div.p14
	{mso-style-name:p14;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"ＭＳ 明朝";
	mso-fareast-theme-font:minor-fareast;}
p.p15, li.p15, div.p15
	{mso-style-name:p15;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-indent:-.5in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"ＭＳ 明朝";
	mso-fareast-theme-font:minor-fareast;}
p.p16, li.p16, div.p16
	{mso-style-name:p16;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.5in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Times;
	mso-fareast-font-family:"ＭＳ 明朝";
	mso-fareast-theme-font:minor-fareast;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.p17, li.p17, div.p17
	{mso-style-name:p17;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Times;
	mso-fareast-font-family:"ＭＳ 明朝";
	mso-fareast-theme-font:minor-fareast;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.p18, li.p18, div.p18
	{mso-style-name:p18;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Times;
	mso-fareast-font-family:"ＭＳ 明朝";
	mso-fareast-theme-font:minor-fareast;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.p19, li.p19, div.p19
	{mso-style-name:p19;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-indent:-31.5pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Times;
	mso-fareast-font-family:"ＭＳ 明朝";
	mso-fareast-theme-font:minor-fareast;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
p.p20, li.p20, div.p20
	{mso-style-name:p20;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Helvetica;
	mso-fareast-font-family:"ＭＳ 明朝";
	mso-fareast-theme-font:minor-fareast;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
span.s1
	{mso-style-name:s1;
	mso-style-unhide:no;
	mso-ansi-font-size:7.0pt;
	mso-bidi-font-size:7.0pt;
	font-family:"Times New Roman";
	mso-ascii-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
span.s2
	{mso-style-name:s2;
	mso-style-unhide:no;
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Times New Roman";
	mso-ascii-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
span.s3
	{mso-style-name:s3;
	mso-style-unhide:no;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ascii-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
span.s4
	{mso-style-name:s4;
	mso-style-unhide:no;
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:Times;
	mso-ascii-font-family:Times;
	mso-hansi-font-family:Times;}
span.s5
	{mso-style-name:s5;
	mso-style-unhide:no;
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Times New Roman";
	mso-ascii-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-size:10.0pt;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;}
@page WordSection1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";}
</style>
<![endif]-->
<meta http-equiv=Content-Style-Type content="text/css">
<meta name=CocoaVersion content=1138.23>
</head>

<body bgcolor=white lang=EN-US style='tab-interval:.5in'>

<div class=WordSection1>

<p class=p1><b>CURRICULUM VITAE</b></p>

<p class=p2><b>&nbsp;</b></p>

<p class=p1><b>Charlotte DeCroes Jacobs, M.D.</b></p>

<p class=p2>Drs. Ben and A. Jess Shenson Professor of Medicine (Emerita)</p>

<p class=p2>Department of Medicine, Division of Oncology</p>

<p class=p2>Stanford University School of Medicine</p>

<p class=p3><b>&nbsp;</b></p>

<p class=p3><b>Education:</b></p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1968&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
BA Magna Cum Laude, University of Rochester, Rochester NY</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1972&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
MD Washington University School of Medicine, St. Louis MO</p>

<p class=p3><b>&nbsp;</b></p>

<p class=p3><b>Postgraduate Training:</b></p>

<p class=p4>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1972-74&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intern, Junior Resident, Department of Medicine</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Washington University School of Medicine, St. Louis MO</p>

<p class=p4>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1974-75&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Senior Resident, Department of Medicine,</p>

<p class=p4>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;University of California, San Francisco CA</p>

<p class=p4>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1975-77&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Postdoctoral Fellow, Division of Oncology</p>

<p class=p4>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Stanford University School of Medicine, Stanford CA</p>

<p class=p3><b>&nbsp;</b></p>

<p class=p3><b>Academic Appointments:</b></p>

<p class=p4><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</b>2009-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Professor of Medicine (Emerita) Stanford University</p>

<p class=p4>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1996-2009&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Professor of
Medicine, Division of Oncology, Stanford University</p>

<p class=p4>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1992-96&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Associate Professor of Medicine, Division of Oncology</p>

<p class=p4>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1986-92&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Associate Professor of Medicine (Clinical), Division of Oncology</p>

<p class=p4>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1980-86&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assistant Professor of Medicine, Division of Oncology</p>

<p class=p4>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1977-80&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acting Assistant Professor of Medicine, Division of Oncology</p>

<p class=p3>&nbsp;</p>

<p class=p3><b>Administrative Appointments:</b></p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2010-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Staff physician, VA Palo Alto Health Care System</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1997-01&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Director, Clinical Cancer Center at Stanford</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1998-99&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Director, Clinical Cancer Program, UCSF Stanford Health Care</p>

<p class=p4>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1990-97&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Senior Associate Dean for Education and Student Affairs, School of Medicine</p>

<p class=p4>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1988-90&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Co-director, Fellowship Training Program, Division of Oncology</p>

<p class=p4>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1977-90&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Director, Oncology Day Care Center, Stanford University Medical Center</p>

<p class=p5><o:p>&nbsp;</o:p></p>

<p class=p4>&nbsp;</p>

<p class=p3><b>Honors:</b></p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <i>Undergraduate:</i></p>

<p class=p3><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b>1968&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Phi Beta Kappa</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1968&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Janet Park Howell Award in Science</p>

<p class=p3><b>&nbsp;</b></p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <i>Medical School:</i></p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1971&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Alpha Omega Alpha</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1972&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Missouri State Medical Association Award</p>

<p class=p6>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1972&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Janet Glasgow Scholastic Citation Award</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1971&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Medical Alumni Scholarship Award</p>

<p class=p6>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1969-70&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Lange Medical Book Award</p>

<p class=p7>&nbsp;</p>

<p class=p3><i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Faculty:</i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1981&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
American Cancer Society, Junior Faculty Scholarship</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1987-89&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
University Fellow</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1983-87&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Kaiser Foundation Award for Clinical Teaching</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1986<span class=s1><span style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span>Kaiser Foundation Award for Innovative and Outstanding
Contribution</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
to Medical Education</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1985&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Kaiser Foundation Award for Preclinical Teaching</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1990&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Presidential Citation from American Society for Head and Neck Surgery</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1990&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Arthur L. Bloomfield Award for Excellence in Teaching Clinical Medicine</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1990&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Alwin C. Rambar Award for Excellence in Patient Care</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1991&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Kaiser Foundation Award for Excellence in Clinical Teaching</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1993&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Kaiser Foundation Award for Innovative and Outstanding</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Contribution to Medical Education</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1993&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Aphrodite Hofsommer Award for outstanding academic accomplishments,
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Washington University</p>

<p class=p4>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1995&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Laura Hadad Visiting Professorship, Georgetown University</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1997&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Patricia R. Woodard Memorial Lecture, St. Francis Memorial Hospital,</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
San Francisco, CA</p>

<p class=p4>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1997&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Edwin C.Yoder Honor Lecture, St. Joseph Medical Center, Tacoma, WA</p>

<p class=p9>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1999<span class=s1><span style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Drs. Ben and A. Jess Shenson Professorship in the School of
Medicine</p>

<p class=p10>2002&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Alumni Achievement Award, Washington University School of
Medicine,&nbsp;&nbsp;&nbsp;</p>

<p class=p4><b>&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</b>St. Louis</p>

<p class=p8>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2007<span class=s1><span style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Distinguished Alumni Award, Washington University in St. Louis</p>

<p class=p10>2007&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
American Society of Clinical Oncology Statesman Award</p>

<p class=p3><b>&nbsp;</b></p>

<p class=p3><b>Professional Memberships:</b></p>

<p class=p3><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</b>Alpha Omega Alpha</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
American Society of Clinical Oncology</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Amnesty International</p>

<p class=p5><o:p>&nbsp;</o:p></p>

<p class=p3><b>National Committees and Administrative Activities:</b></p>

<p class=p3><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b>2005
-10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
National Comprehensive Cancer Network (NCCN) Soft Tissue Sarcoma</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Guidelines Committee</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2000&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Editorial Board, <i>Current Treatment Options in Oncology</i></p>

<p class=p10>1999
-10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
National Comprehensive Cancer Network (NCCN) Unknown Primary</p>

<p class=p10>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Guidelines Committee</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1998-02&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Cancer Research Council, Department of Health Services, State of California</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Vice Chairman, 1999-02</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1996-98&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
American College of Physicians, Writing Committee for</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Medical Knowledge Self Assessment Program (MKSAP) XI</p>

<p class=p9>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1994-01<span class=s1><span style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>National Comprehensive Cancer Network (NCCN) Board of Directors</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
American Society of Clinical Oncology</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1992-95&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Board of Directors</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1995&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Strategic Planning Group</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1994&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Oncology Manpower Committee</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1994-95&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Conflict of Interest Subcommittee</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1993-95&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Health Services Committee</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1989&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Nominations Committee</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1986&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Education Planning Committee</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1990&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Third International Conference on Head and Neck Cancer Program Committee</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1989-90&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
American Society for Head and Neck Surgery Scientific Program Committee</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1987&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
American College of Physicians, Writing Committee for MKSAP VIII</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1985-88&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
PDQ Extramural Board Reviewer</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1985-87&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
American Federation of Clinical Research, Stanford Representative</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1984-86&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Head and Neck Intergroup, Founder and first Chairman</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1982-86&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
National Head and Neck Contracts Group</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Executive Committee, Writing Committee</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1982-86&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
FDA Oncologic Drug Advisory Board</p>

<p class=p3><i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </i>1991-92&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Editorial Board, <i>Current Opinion in Oncology</i></p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1987-93&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Editorial Board, <i>Head and Neck Surgery</i></p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1987
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Editorial Board, <i>American Journal of Clinical Oncology</i></p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p class=p3><b>University Committees and</b><span class=s2><b><span
style='font-size:9.0pt'> </span></b></span><b>Administrative Activities:</b></p>

<p class=p3><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b>2008-10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Committee on Trusteeship, Board of Trustees, Stanford University</p>

<p class=p3><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b>2008-09&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Search Committee, Thoracic Oncology (Chair)</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
2008-09&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Medical Oncology Task Force</p>

<p class=p3><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b>2008&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Search
Committee, Orthopedic Oncology</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2007&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Scientific
Review Committee, Cancer Center</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2007-09
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Disease
Leadership Group, Sarcoma</p>

<p class=p3><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b>2006-09&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Search Committee, Director Breast Cancer Program&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p class=p10>2005
-06&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Search Committee, Head &amp; Neck Oncology (Chair)</p>

<p class=p10>2005
-06&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Executive Advisory Committee of the Office of Diversity and Leadership</p>

<p class=p10>2005 -06
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Disease
Management Group, Stanford Cancer Center</p>

<p class=p10>2005&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;LCME Subcommittee on Educational Objectives and Structure</p>

<p class=p10>2004
-08&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Search Committee, Ophthalmology</p>

<p class=p10>2004
-05&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Search Committee, GI Oncology</p>

<p class=p10>2004
-05&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Search Committee, Head &amp; Neck Surgery</p>

<p class=p10>2004-06&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stanford University Faculty Senate</p>

<p class=p10>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;University Senate Steering Committee, 2005-2006&nbsp;&nbsp;&nbsp;</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2003&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Center for Cancer Treatment and Prevention Business Planning Executive Group</p>

<p class=p10>2003
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Oncology Informatics Steering Committee</p>

<p class=p10>2002-03&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Search Committee, Otolaryngology/Head and Neck Surgery</p>

<p class=p10>2001 -02
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Search
Committee, Neuro-Oncology</p>

<p class=p10>2001&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Medical Education Strategic Planning Committee</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2000-01
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Medical Center Strategic Planning Group</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2000-01
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Medical Center Internal Governing Council</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2000
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Deans Search Committee, School of Medicine</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1999
-2009&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Executive Committee,
Northern California Tumor Board at Silverado</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p class=p3><b>University Committees and</b><span class=s2><b><span
style='font-size:9.0pt'> </span></b></span><b>Administrative Activities </b>(Continued)<b>:</b></p>

<p class=p3><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b>1998-99&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Strategic Alliance Group, UCSF Stanford Health Care</p>

<p class=p3><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b>1998-99&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
International Advisory Committee, UCSF Stanford Health Care</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1998-99&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Cancer Leadership Group, UCSF Stanford Health Care</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1998-99&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Cancer Center Steering Committee, UCSF Cancer Center</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1997-99,99-01&nbsp;&nbsp;&nbsp;&nbsp;Stanford
University Faculty Senate</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;University Senate Steering Committee, 2000-01&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1994
-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Clinical Cancer Center Steering Committee</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1993-94&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Commission on Undergraduate Education</p>

<p class=p4>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1993-94&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
President's Medical Center Task Force – External Affiliations Working Group</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1993&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Provosts Committee on Postdoctoral Scholars, Chair</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1992-93&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Provosts Committee on Budget Implementation</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1992-93, 94-96&nbsp; Council on
Diversity, School of Medicine</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1992&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
University Commencement Committee</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1988-92,94-96&nbsp;&nbsp; Stanford
University Faculty Senate</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Committee on Committees, 1989-90, 95-96</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1983-89&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Medical School Faculty Senate</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Chairman, 1988-89</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Committee of Five, 1983-84, 87-89</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1988-89&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Affirmative Action Committee, School of Medicine</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1988-89&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Committee on Student Awards, Chairman</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1988-89&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Management Group to the Chairman, Department of Medicine</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1988-89&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Committee on Faculty Practice Program Organization and Financial Relationships</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1988-89&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Search Committee, Gynecology and Obstetrics Chair</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1988-90&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Planning Group for Cancer Treatment Center</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1986-88&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Faculty Practice Program Strategic Planning Committee</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1986-90&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
File Reviewer for Admissions Committee, School of Medicine</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1985-87&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Faculty Practice Budget Committee, Department of Medicine</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1985-87&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Principal Investigator at Stanford, Northern California Oncology Group (NCOG)</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Chairman, Head and Neck Committee</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Member, Pharmacology and Lymphoma Committees</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1982-87&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Committee on Well-Being of Medical Students</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chairman, 1982-84</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1981-89&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Professional Practice Committee</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1981-85&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Internship Selection Committee, Department of Medicine</p>

<p class=p3><b>Certification:</b></p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1972&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
National Board of Medical Examiners</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1975&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
American Board of Internal Medicine</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1977&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
American Board of Internal Medicine (Medical Oncology)</p>

<p class=p3><b>License:</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p class=p3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
1974&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
California</p>

<p class=p5><o:p>&nbsp;</o:p></p>

<p class=p3><b>PUBLISHED ARTICLES</b></p>

<p class=p11>&nbsp;</p>

<p class=p12>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DeCroes C*, Abood
LG.&nbsp; Histology of a uniquely organized nervous system in the salamander
neural tissue-limb implant.&nbsp; Int J Neurosci 1972;3:237-50.</p>

<p class=p12>&nbsp;</p>

<p class=p12>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C, Portlock
CS, Rosenberg SA.&nbsp; Prednisone in MOPP chemotherapy for Hodgkin's
disease.&nbsp; Br Med J 1976;2:1469-71.</p>

<p class=p11>&nbsp;</p>

<p class=p12>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Kim H, Jacobs C,
Warnke RA, Dorfman RF.&nbsp; Malignant lymphoma with high content of epitheloid
histiocytes.&nbsp; Cancer 1978;41:620-35.</p>

<p class=p11>&nbsp;</p>

<p class=p12>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C, Bertino JR,
Goffinet DR, Fee WE, Goode RL.&nbsp; Cis-platinum chemotherapy in head and neck
cancers.&nbsp; Otolaryngol Head Neck Surg 1978;86:780-3.</p>

<p class=p11>&nbsp;</p>

<p class=p12>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C, Bertino JR,
Goffinet DR, Fee WE, Goode RL.&nbsp; 24-hour infusion of cis-platinum in head
and neck cancers.&nbsp; Cancer 1978;42:2135-40.</p>

<p class=p13>&nbsp;</p>

<p class=p12>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C.&nbsp; A
patient teaching tool - Hodgkin's disease.&nbsp; Cancer Nursing 1979;2:153-66.</p>

<p class=p13>&nbsp;</p>

<p class=p12>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Levi J, Jacobs C,
Kalman SM, McTigue M, Weiner MW.&nbsp; Mechanism of cis-platinum
nephrotoxicity:&nbsp; I.&nbsp; Effects on sulfhydryl groups in rat
kidneys.&nbsp; J Pharmacol Exp Ther 1980;213:545-50.</p>

<p class=p13>&nbsp;</p>

<p class=p12>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dobyan DC, Levi J,
Jacobs C, Kosek J, Weiner MW.&nbsp; Mechanism of cis-platinum
nephrotoxicity:&nbsp;II.&nbsp;&nbsp;Morphologic observations.&nbsp; J Pharmacol
Exp Ther 1980;213:551-6.</p>

<p class=p13>&nbsp;</p>

<p class=p12>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C, Kalman SM,
Tretton M, Weiner MW.&nbsp; Renal handling of cis-diamminedichloroplatinum
(II). Cancer Treat Rep 1980;64:1223-6.</p>

<p class=p14>&nbsp;</p>

<p class=p15>10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C, Donaldson SS,
Rosenberg SA, Kaplan HS.&nbsp; Management of the pregnant patient with
Hodgkin's disease.&nbsp; Ann Intern Med 1981;95:669-75.</p>

<p class=p14>&nbsp;</p>

<p class=p15>11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mead GM,&nbsp; Jacobs
C.&nbsp; Changing role of chemotherapy in the treatment of head and neck
cancer.&nbsp; Am J Med 1982;73:582-95.</p>

<p class=p14>&nbsp;</p>

<p class=p15>12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C.&nbsp;
Chemotherapy and combined modality treatment of head and neck cancer. Current
Concepts in Oncology, 1982:4:17-21.</p>

<p class=p14>&nbsp;</p>

<p class=p15>13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C.&nbsp; Use of
methotrexate and 5-FU for recurrent head and neck cancer.&nbsp; Cancer Treat
Rep 1982;66:1925-8.</p>

<p class=p14>&nbsp;</p>

<p class=p15>14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C, Ross RD, Walker
IM, Stockdale FE.&nbsp; Behavior of cancer patients:&nbsp; A randomized study
of the effects of education and peer support groups.&nbsp; Am J Clin Oncol
1983;6:347-50.</p>

<p class=p3>&nbsp;</p>

<p class=p15>15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C, Meyers F,
Hendrickson C, Kohler M, Carter S.&nbsp; A randomized phase III study of</p>

<p class=p15>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
cisplatin with or without methotrexate for recurrent squamous cell carcinoma of
the head and</p>

<p class=p15>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
neck.&nbsp; Cancer 1983;52:1563-9.</p>

<p class=p3>&nbsp;</p>

<p class=p3>*Maiden Name</p>

<p class=p3>&nbsp;</p>

<p class=p15>16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Campbell AB, Kalman SM,
Jacobs C.&nbsp; Plasma platinum levels:&nbsp; Relationship to cisplatin dose
and nephrotoxicity.&nbsp; Cancer Treat Rep 1983;67:169-72.</p>

<p class=p3>&nbsp;</p>

<p class=p15>17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Coleman CN, Friedman MK,
Jacobs C, Halsey J, Ignoffo R, Leibel S, Hirst VK, Gribble M, Carter SK,
Phillips TL.&nbsp; Phase I trial of intravenous L-phenylalanine mustard plus
the sensitizer Misonidazole.&nbsp; Cancer Res 1983;43:5022-5.</p>

<p class=p3>&nbsp;</p>

<p class=p15>18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C, Coleman CN, Rich
L, Hirst K. Weiner MW.&nbsp; Inhibition of cis-diamminedichloroplatinum
secretion by the human kidney with probenecid.&nbsp; Cancer Res 1984;44:3632-5.</p>

<p class=p3>&nbsp;</p>

<p class=p15>19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Schreiber DP, Jacobs C,
Rosenberg SA, Cox RS, Hoppe RT.&nbsp; The potential benefits of therapeutic
splenectomy for patients with Hodgkin's disease and non-Hodgkin's
lymphomas.&nbsp; Int J Radiat Oncol Biol Phys 1985;11:31-6.</p>

<p class=p3>&nbsp;</p>

<p class=p15>20.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C, Hoppe RT.&nbsp;
Non-Hodgkin's lymphomas of head and neck extranodal sites.&nbsp; Int J Radiat
Oncol Biol Phys 1985;11:357-64.</p>

<p class=p3>&nbsp;</p>

<p class=p15>21.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Connors JM, Andiman WA,
Howarth CB, Liu E, Merigan TC, Savage ME, Jacobs C.&nbsp; Treatment of
nasopharyngeal carcinoma with&nbsp; human leukocyte interferon.&nbsp; J Clin
Oncol 1985;3:813-7.</p>

<p class=p3>&nbsp;</p>

<p class=p15>22.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Kent DL, Shortliffe EH,
Carlson RW, Bischoff MB, Jacobs CD.&nbsp; Improvements in data collection
through physician use of a computer-based chemotherapy treatment
consultant.&nbsp; J Clin Oncol 1985;3:1409-17.</p>

<p class=p3>&nbsp;</p>

<p class=p15>23.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hickam DH, Shortliffe EH,
Bischoff MB, Scott AC, Jacobs CD.&nbsp; The treatment advice of a
computer-based cancer chemotherapy protocol advisor.&nbsp; Ann Intern Med
1985;103:928-36.</p>

<p class=p3>&nbsp;</p>

<p class=p15>24.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C, Weiss L, Hoppe
RT.&nbsp; The management of extranodal head and neck lymphomas.&nbsp; Arch
Otolaryngol Head Neck Surg 1986;112:654-8.</p>

<p class=p3>&nbsp;</p>

<p class=p15>25.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bernstein JI, Jacobs C,
Meyers F, Rich-Goffinet L, Tanaka L.&nbsp; A phase II study of cisplatin and
cytosine arabinoside for recurrent squamous cell carcinoma of the head and
neck.&nbsp; Am J Clin Oncol 1986;9:58-60.</p>

<p class=p3>&nbsp;</p>

<p class=p15>26.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fu KK, Phillips TL,
Silverberg IJ, Jacobs C, Goffinet DR, Chun C, Friedman MA, Kohler M, McWhirter
K, Carter SK.&nbsp; Combined radiotherapy and chemotherapy with bleomycin and
methotrexate for advanced inoperable head and neck cancer:&nbsp; Update of a
Northern California Oncology Group randomized trial.&nbsp; J Clin Oncol
1987;5:1410-8.</p>

<p class=p3>&nbsp;</p>

<p class=p15>27.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tseng A Jr., Jacobs C,
Coleman CN, Horning SJ, Lewis BJ, Rosenberg SA.&nbsp; Third-line chemotherapy
for resistant Hodgkin's disease with lomustine, etoposide, and
methotrexate.&nbsp; Cancer Treat Rep 1987;71:475-8.</p>

<p class=p3>&nbsp;</p>

<p class=p15>28.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Venook AP, Tseng A Jr.,
Meyers FJ, Silverberg I, Boles R, Fu KK, Jacobs CD.&nbsp; Cisplatin,
doxorubicin, and 5-fluorouracil chemotherapy for salivary gland
malignancies:&nbsp; A pilot study of the Northern California Oncology
Group.&nbsp; J Clin Oncol 1987;5:951-5.</p>

<p class=p15>&nbsp;</p>

<p class=p15>29.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C.&nbsp; Treatment
of recurrent squamous cell head and neck cancer. &nbsp;Advances in Oncology
1987;3:16-22.</p>

<p class=p3>&nbsp;</p>

<p class=p15>30.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C.*&nbsp; Adjuvant
chemotherapy for advanced head and neck squamous carcinoma.&nbsp; A Final
Report of the Head and Neck Contracts Program.&nbsp; Cancer 1987;60:301-11.</p>

<p class=p3>&nbsp;</p>

<p class=p15>31.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C, Goffinet DR,
Goffinet L, Kohler M, Fee W.&nbsp; Chemotherapy as a substitute for surgery in
the treatment of advanced resectable head and neck cancer.&nbsp; A report from
the Northern California Oncology Group.&nbsp; Cancer 1987;60:1178-83.</p>

<p class=p15>&nbsp;</p>

<p class=p15>32.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tseng A Jr., Jacobs C,
Coleman CN, Horning SJ, Lewis BJ, Rosenberg SA.&nbsp; Treatment of refractory
non-Hodgkin's lymphomas of unfavorable histology with teniposide, cytarabine,
and cisplatin.&nbsp; Cancer Treat Rep 1987;71:659-60.</p>

<p class=p3>&nbsp;</p>

<p class=p15>33.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Coleman CN, Carlson RW,
Halsey J, Kohler M, Gribble M, Sikic BI, Jacobs C.&nbsp; Enhancement of the
clinical activity of melphalan by the hypoxic cell sensitizer
misonidazole.&nbsp; Cancer&nbsp;Res&nbsp;1988;48:3528-32.</p>

<p class=p15>&nbsp;</p>

<p class=p15>34.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Levick S, Jacobs C, Loukas
DF, Gordon DH, Meyskens FL, Uhm K.&nbsp; Naproxen sodium in treatment of bone
pain due to metastatic cancer.&nbsp; Pain 1988;35:253-8.</p>

<p class=p15>&nbsp;</p>

<p class=p15>35.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dimery IW, Jacobs C, Tseng
A, Saks S, Pearson G, Hong WK, Gutterman JU.&nbsp; Recombinant5interferon-gamma<span
style='font-family:Symbol;mso-ascii-font-family:"Times New Roman";mso-hansi-font-family:
"Times New Roman";mso-char-type:symbol;mso-symbol-font-family:Symbol'><span
style='mso-char-type:symbol;mso-symbol-font-family:Symbol'> </span></span>in
the treatment of recurrent nasopharyngeal carcinoma.&nbsp; J Biol Resp Mod
1989;8:221-6.</p>

<p class=p15>&nbsp;</p>

<p class=p15>36.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Audeh MW, Jacobs CD, Davis
TE, Carlson RW.&nbsp; A phase II trial of carbetimer for the treatment of
colorectal cancer:&nbsp; a trial of the Northern California Oncology
Group.&nbsp; Am J Cln Oncol. 1990;13(4): 324-6.</p>

<p class=p15>&nbsp;</p>

<p class=p15>37.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C, Makuch R..&nbsp;
Efficacy of adjuvant chemotherapy for patients with resectable head and neck
cancer - a subset analysis of the head and neck contracts program.&nbsp; J Clin
Oncol 1990;8:838-47.</p>

<p class=p15>&nbsp;</p>

<p class=p15>38.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Berry JM, Jacobs C, Sikic
BI,Halsey J, Borch R.&nbsp; Modification of cisplatin toxicity with
diethyldithiocarbamate.&nbsp; J Clin Oncol 1990;8:1585-90 .</p>

<p class=p15>&nbsp;</p>

<p class=p15>39.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C. The internist in
the management of head and neck cancer. &nbsp;Ann Intern Med 1990;113(10):771-8.</p>

<p class=p15>&nbsp;</p>

<p class=p15>40.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C, Kaubisch S,
Halsey J, Lum B, Gosland M, Coleman CN, Sikic B.&nbsp; Use of probenecid as a
chemoprotector against cisplatin nephrotoxicity. Cancer 1991;67(6):1518-24.</p>

<p class=p15>&nbsp;</p>

<p class=p15>41.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vokes EE, Dimery I, Jacobs
CD, et al.&nbsp; A phase II study of piritrexim in combination with
methotrexate in recurrent and metastatic head and neck cancer.&nbsp; Cancer
1991 67(9):2253-57.</p>

<p class=p15>&nbsp;</p>

<p class=p15>42. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C. Neoadjuvant and
adjuvant treatment of head and neck cancer. Seminars in Oncology
1991;18:504-14.</p>

<p class=p15>&nbsp;</p>

<p class=p15>* Writing Committee</p>

<p class=p15>43.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C, Lyman G,
Velez-Garcia, et al.&nbsp; A phase III randomized study comparing cisplatin and
fluorouracil as single agents and in combination for advanced squamous cell
carcinoma of the head and neck.&nbsp; J Clin Oncol 1992;10:257-63.</p>

<p class=p15>&nbsp;</p>

<p class=p15>44.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nelson M, Jacobs C, Cuban
L.&nbsp; Concepts of Curriculum.&nbsp; Teaching and Learning in Medicine&nbsp;
1992;4:202-5</p>

<p class=p15>&nbsp;</p>

<p class=p15>45.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C, Moreno B,
Blaschke T.&nbsp; In Progress:&nbsp; A multimodality approach to preparation
for clinical medicine.&nbsp; Acad Med 1995;70(5):441-2.&nbsp;</p>

<p class=p15>&nbsp;</p>

<p class=p15>46.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C, Bergen M.&nbsp;
In Progress:&nbsp; A sexual harassment workshop for medical students.&nbsp;
Acad Med 1995;70(5):434-5.</p>

<p class=p15>&nbsp;</p>

<p class=p15>47.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C, Pinto H.&nbsp;
Adjuvant and neoadjuvant treatment of head and neck cancers:&nbsp; the next
chapter.&nbsp; Seminars in Oncology 1995;22(6):540-52.</p>

<p class=p15>&nbsp;</p>

<p class=p15>48.<span class=s1><span style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Jacobs CD, Cross PC.&nbsp; The value of medical student research
— the experience at Stanford University School of Medicine.&nbsp; Medical
Education 1995;29:342-6.</p>

<p class=p3>&nbsp;</p>

<p class=p15>49.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bergen MR, Guarino CM,
Jacobs CJ.&nbsp; A climate survey for medical students:&nbsp; a means to assess
change.&nbsp; Evaluation and the Health Professions 1996;19(1):30-47.</p>

<p class=p15>&nbsp;</p>

<p class=p15>50.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Smith K, Moreno E, Jacobs
C.&nbsp; The curriculum indexing database for Stanford University School of
Medicine.&nbsp; Teaching and Learning in Med 1996; 8(1): 48-52.</p>

<p class=p15>&nbsp;</p>

<p class=p15>51.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs CJ, Van der Pas
M.&nbsp; A multicenter maintenance study of oral pilocarpine tablets for
radiation-induced xerostomia.&nbsp; Oncol 1996; 10:16-20.</p>

<p class=p15>&nbsp;</p>

<p class=p15>52.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amer Soc Clin Oncol (Mayer
RJ, Antman KH, Bailes JS, Bloomfield CD, Canellos GP, Glick JG, Jacobs
CD).&nbsp; Status of the Medical Oncology Workforce.&nbsp; J Clin Onc
1996;14(9):2612-21.</p>

<p class=p15>&nbsp;</p>

<p class=p15>53.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vosti KL, Bloch DA, Jacobs
CD.&nbsp; The relationship of clinical knowledge to months of clinical training
among medical students.&nbsp; Acad Med 1997;72(4):305-7.</p>

<p class=p15>&nbsp;</p>

<p class=p15>54.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ciesielski-Carlucci C,
Leong P, Jacobs C.&nbsp; A case report of anaphylaxis from cisplatin/taxol and
a review of their hypersensitivity reaction profiles.&nbsp; Am J Clin Onc
1997;20(4):373-5.</p>

<p class=p15>&nbsp;</p>

<p class=p15>55.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hausdorff J, Davis E, Long
G, Hoppe R, van der Pas M, Lassman C, Kamel O, Jacobs C.&nbsp; Non-HodgkinÕs
lymphoma of the paranasal sinuses: clinical and pathological features, and
response to combined-modality therapy.&nbsp; Cancer J Sci Am 1997;3(5):303-11.</p>

<p class=p15>&nbsp;</p>

<p class=p15>56.<span class=s1><span style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Vosti KL, Jacobs CD.&nbsp; Outcome measurements in postgraduate
year one of graduates from a medical school with a pass/fail grading
system.&nbsp; Acad Med 1999;74(5):547-9.</p>

<p class=p3>&nbsp;</p>

<p class=p15>57.<span class=s1><span style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Yuen A, Jacobs C.&nbsp; Lymphomas of the Head and Neck.&nbsp; Sem
in Oncol 1999;26(3): 338-45.</p>

<p class=p3>&nbsp;</p>

<p class=p15>58.<span class=s1><span style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Jacobs CD, Bergen MR, Korn D.&nbsp; Impact of a program to
diminish gender insensitivity and sexual harassment at a medical school.&nbsp;
Acad Med 2000;75:464-9.</p>

<p class=p3>&nbsp;</p>

<p class=p15>59.<span class=s1><span style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Nguyen DD, Loo BW Jr, Tillman G, Natkunam Y, Cao TM, Vaughan W,
Dorfman RF, Goffinet DR, Jacobs CD, Advani RH. Plasmablastic lymphoma
presenting in a human immunodeficiency virus-negative patient: a case report.
Ann Hematol. 2003 Aug;82(8):521-5. Epub 2003 May 29.</p>

<p class=p3>&nbsp;</p>

<p class=p15>60.<span class=s1><span style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Advani R, Lum BL, Fisher GA, Halsey J, Chin DL, Jacobs CD, Sikic
BI.&nbsp; A phase I trial of liposomal doxorubicin, paclitaxel, and valspodar
(PSC-833), an inhibitor of multidrug resistance.&nbsp; Ann Oncol.&nbsp; 2005
Aug;16:1968-1973</p>

<p class=p3>&nbsp;</p>

<p class=p15>61.<span class=s1><span style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Demetri GD, Baker LH, Benjamin RS, Casper ES, Conrad EU 3<span
class=s3><sup><span style='font-size:10.0pt'>rd</span></sup></span>, DÕAmato
GZ, DeLaney TF, Ettinger DS, Heck R Jr., Heslin MJ, Hutchison RJ, Jacobs CD, et
al. Soft tissue sarcoma. J Natl Compr Canc Netw. 2007 Apr;5(4):364-99.</p>

<p class=p3>&nbsp;</p>

<p class=p15>62.<span class=s1><span style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Lehman NL, Jacobs CD, Holsten PA, et al. Primary paraspinal
leiomyosarcoma invading the cervical spinal canal successfully treated with
surgery, radiotherapy, and chemotherapy. Case report.&nbsp; J Neurosurg Spine.
2007 May;6(5):441-6.</p>

<p class=p3>&nbsp;</p>

<p class=p16><span style='mso-bidi-font-family:"Times New Roman"'>63.</span><span
class=s1><span style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='mso-bidi-font-family:"Times New Roman"'>Elkin A,
Jacobs C.&nbsp;&nbsp; Tamoxifen for salivary gland adenoid cystic carcinoma:
report of two cases.&nbsp; J Cancer Res Clin Oncol (2008) 134:1151-1153<o:p></o:p></span></p>

<p class=p17><span style='mso-bidi-font-family:"Times New Roman"'>&nbsp;<o:p></o:p></span></p>

<p class=p16><span style='mso-bidi-font-family:"Times New Roman"'>64.</span><span
class=s1><span style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='mso-bidi-font-family:"Times New Roman"'>Ettinger DS,
Agulnik M, Cristea M, Eaton K, Fidias PM, Gockerman JP, Hameed O, Handord C,
Harris El, Jacbos CD, et al. Occult Primary. J Natl Compr Canc Netw. 2008
Nov;6(10):1026-60<o:p></o:p></span></p>

<p class=p17><span style='mso-bidi-font-family:"Times New Roman"'>&nbsp;<o:p></o:p></span></p>

<p class=p16><span style='mso-bidi-font-family:"Times New Roman"'>65.</span><span
class=s1><span style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='mso-bidi-font-family:"Times New Roman"'>Gholami S,
Jacobs CD, Kapp DS, Parast LM, Norton JA. The value of surgery for
retroperitoneal sarcoma. Sarcoma. 2009, Epub 2009 Oct. 8<o:p></o:p></span></p>

<p class=p17><span style='mso-bidi-font-family:"Times New Roman"'>&nbsp;<o:p></o:p></span></p>

<p class=p16><span style='mso-bidi-font-family:"Times New Roman"'>66.</span><span
class=s1><span style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='mso-bidi-font-family:"Times New Roman"'>Chandran S,
Petersen J, Jacobs C, Fiorentino D, Doeden K, Lafayette RA. Imatinib in the
treatment of nephrogenic systemic fibrosis. Am J Kidney Dis. 2009
Jan;53(1):129-32.<o:p></o:p></span></p>

<p class=p17><span style='mso-bidi-font-family:"Times New Roman"'>&nbsp;<o:p></o:p></span></p>

<p class=p16><span style='mso-bidi-font-family:"Times New Roman"'>67.</span><span
class=s1><span style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='mso-bidi-font-family:"Times New Roman"'>Brar R, West
R, Witten D, Raman B, Jacobs C, Ganjoo K. Breast angiosarcoma: Case series and
expression of vascular endothelial growth factor. Case Rep Oncol 2009; 2:242-50<o:p></o:p></span></p>

<p class=p17><span style='mso-bidi-font-family:"Times New Roman"'>&nbsp;<o:p></o:p></span></p>

<p class=p16><span style='mso-bidi-font-family:"Times New Roman"'>68.</span><span
class=s1><span style='font-size:7.0pt'>&nbsp;&nbsp;
</span></span><span style='mso-bidi-font-family:"Times New Roman"'>Ganjoo K,
Jacobs C. Antiangiogenesis agents in the treatment of soft tissue sarcomas.
Cancer. 2010 Mar 1;116(5):1177-83.<o:p></o:p></span></p>

<p class=p17><span style='mso-bidi-font-family:"Times New Roman"'>&nbsp;<o:p></o:p></span></p>

<p class=p16><span style='mso-bidi-font-family:"Times New Roman"'>69.</span><span
class=s1><span style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span style='mso-bidi-font-family:"Times New Roman"'>Ganjoo K,
Witten D, Patel M, Espinosa I, La T, Tibshirani, van de Rijn M, Jacobs C, West
RB. The prognostic value of tumor associated macrophages in leiomyosarcoma: a
single institution study. Amer J Clin Oncol (in press).<o:p></o:p></span></p>

<p class=p17><span style='mso-bidi-font-family:"Times New Roman"'>&nbsp;<o:p></o:p></span></p>

<p class=p15>70.<span class=s1><span style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span class=s4>Ganjoo KN, Demetri GD, Jacobs C, </span>Patel S. <br>
Acute myeloid leukemia in patients with gastrointestinal stromal tumors treated
with Gleevac. Leuk Lymphoma. 2009; 50 (11): 1882-4.</p>

<p class=p3>&nbsp;</p>

<p class=p15>71.<span class=s1><span style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Wakelee HA, Takimoto CH, Lopez-Anaya A, Chu Q, Middleton G,
Dunlop D, Ramlau R, Leighl N, Rowinsky EK, Hao D, Zatloukal P, Jacobs CD, Rodon
J.&nbsp; The effect of bexarotene plus chemotherapy in patients with advanced
non-small cell lung cancer. <br>
Cancer Chemother Pharmacol. 2011.</p>

<p class=p3>&nbsp;</p>

<p class=p15>72.<span class=s1><span style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Wakelee HA, Middleton G, Dunlop D, Ramlau R, Leighl N, Hao D,
Lopez-Anaya A, Zatloukal P, Jacobs CD. A phase I pharmacokinetic study of
bexarotene with vinorelbine and cisplatin in patients with advanced non-small
cell lung cancer (NSCLC). Chemother Pharmacol. 2011.</p>

<p class=p17><span style='mso-bidi-font-family:"Times New Roman"'>&nbsp;<o:p></o:p></span></p>

<p class=p18><span style='mso-bidi-font-family:"Times New Roman"'>&nbsp;<o:p></o:p></span></p>

<p class=p3><b>PUBLISHED CONFERENCE PROCEEDINGS</b></p>

<p class=p15>&nbsp;</p>

<p class=p15>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Weiner MW,
Jacobs C.&nbsp; Mechanism of cisplatin nephrotoxicity.&nbsp; Fed Proc Symposium
on Metal Toxicity 1983;42:2974-8.</p>

<p class=p15>&nbsp;</p>

<p class=p15>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C.
Probenecid and diethyldithiocarbamate as modifiers of cisplatin toxicity.&nbsp;
In:&nbsp; Howell SB (ed) Proceedings of the Sixth International Symposium on
Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy.&nbsp;
New York: Plenum Publishing Corp&nbsp; 1991;493-500.</p>

<p class=p15>&nbsp;</p>

<p class=p3>&nbsp;</p>

<p class=p3>&nbsp;</p>

<p class=p3><b>PUBLISHED BOOKS/SYMPOSIA</b></p>

<p class=p3><b>&nbsp;</b></p>

<p class=p12>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C (ed).&nbsp; <i>Cancers
of the Head and Neck</i>.&nbsp; MA:&nbsp; Martinus Nijhoff Publishers, 1987.</p>

<p class=p12>&nbsp;</p>

<p class=p12>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <i>Medical Knowledge
Self-Assessment Program VIII</i>.&nbsp; American College of Physicians, 1988.</p>

<p class=p12>&nbsp;</p>

<p class=p12>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C, Goffinet
DR, Fee WE.&nbsp; <i>Head and Neck Squamous Cancers</i>.&nbsp; Year Book
Medical Publishers, Chicago, Jan/Feb 1990.</p>

<p class=p12>&nbsp;</p>

<p class=p12>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C, (ed).&nbsp;
<i>Carcinomas of the Head and Neck.</i>&nbsp; Boston: Kluwer Academic
Publishers, 1990.</p>

<p class=p12>&nbsp;</p>

<p class=p12>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <i>Medical Knowledge
Self-Assessment Program VIII</i>.&nbsp; American College of Physicians, 1998.</p>

<p class=p12>&nbsp;</p>

<p class=p19><span class=s5>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs
CD.&nbsp; </span><i><span style='mso-bidi-font-family:"Times New Roman"'>Henry
Kaplan and the Story of HodgkinÕs Disease</span></i><span class=s5>.&nbsp;</span><span
style='mso-bidi-font-family:"Times New Roman"'><o:p></o:p></span></p>

<p class=p12>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Stanford: Stanford Press, 2010.</p>

<p class=p3>&nbsp;</p>

<p class=p3>&nbsp;</p>

<p class=p3>&nbsp;</p>

<p class=p3><b>PUBLISHED BOOK CHAPTERS</b></p>

<p class=p3><b>&nbsp;</b></p>

<p class=p12>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C.&nbsp; The
role of cisplatin in the treatment of recurrent head and neck cancer.&nbsp;
In:&nbsp; Prestayko AW, Crooke ST, Carter SK (eds) <i>Cisplatin Current Status
and New Developments.</i>&nbsp; New York:&nbsp; Academic Press, 1980;423-30.</p>

<p class=p3>&nbsp;</p>

<p class=p12>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C.&nbsp;
High-dose methotrexate and cis-platinum in the treatment of recurrent head and
neck cancer.&nbsp; In:&nbsp; Carter SK, Sakurai Y, Umezawa H (eds)&nbsp; <i>Recent
Results in Cancer Research.</i>&nbsp; Berlin: &nbsp;Springer-Verlag,
1981;290-5.</p>

<p class=p11>&nbsp;</p>

<p class=p12>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C, Ross
R.&nbsp; Psychological assessment of cancer patients.&nbsp; In:&nbsp; Williams
CJ, Whitehouse JMA (eds)&nbsp; <i>Recent Advances in Clinical Oncology</i>.&nbsp;
London:&nbsp; Churchill Livingstone, 1982;365-74.</p>

<p class=p11>&nbsp;</p>

<p class=p12>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C.&nbsp; The
use of chemotherapy in combination with radiotherapy in the treatment of head
and neck squamous cancers.&nbsp; In:&nbsp; Wolf GT (ed)&nbsp; <i>Head and Neck
Oncology.</i>&nbsp; Boston:&nbsp; Martinus Nijhoff Publishers, 1984;265-86.</p>

<p class=p11>&nbsp;</p>

<p class=p12>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shortliffe EH, Scott
AC, Bischoff MB, Campbell AB, van Melle W,<b> </b>Jacobs CD.&nbsp; An expert
system for oncology protocol management.&nbsp; Rule-based expert systems.&nbsp;
In:&nbsp; Buchanan BG, Shortliffe EH (eds)&nbsp; <i>The Mycin Experiments of
the Stanford Heuristic Programming Project.</i>&nbsp; CA:&nbsp; Addison-Wesley
Company, 1984;653-65.</p>

<p class=p11>&nbsp;</p>

<p class=p12>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs CD.&nbsp; The
role of chemotherapy in the treatment of head and neck cancer.&nbsp; In:&nbsp;
Sikic BI, Rozencweig M, Carter SK (eds)&nbsp; <i>Bleomycin Chemotherapy.</i>&nbsp;
New York:&nbsp; Academic Press, 1985;79-93.</p>

<p class=p11>&nbsp;</p>

<p class=p12>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C.&nbsp; The
handling of platinum by the human kidney.&nbsp; In:&nbsp; McBrien DCH, Slater
TF (eds)&nbsp; <i>Biochemical Mechanisms of Platinum Antitumor Drugs.</i>&nbsp;
Oxford:&nbsp; IRL Press Limited, 1986;147-70.</p>

<p class=p11>&nbsp;</p>

<p class=p12>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs CD.&nbsp;
Biophysiology of antineoplastic chemotherapy for head and neck cancer.&nbsp;
In:&nbsp; Cummings CW, Fredrickson, Harker LE, Krause CJ, Schuller DE (eds) <i>Otolaryngology-Head
and Neck Surgery</i>.&nbsp; St. Louis:&nbsp; C.V. Mosby Co, 1986;51-72.</p>

<p class=p11>&nbsp;</p>

<p class=p12>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Connors JM, Jacobs
C.&nbsp; Nasopharyngeal carcinoma:&nbsp; Relationship to Epstein-Barr virus and
treatment with Interferon.&nbsp; In:&nbsp; Jacobs C (ed) <i>Cancers of the Head
and Neck</i>.&nbsp; MA:&nbsp; Martinus Nijhoff Publishers, 1987;167-75.</p>

<p class=p3>&nbsp;</p>

<p class=p15>10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C.&nbsp; Lymphomas
of extranodal head and neck sites.&nbsp; In:&nbsp; Jacobs C (ed) <i>Cancers of
the Head and Neck.</i>&nbsp; MA:&nbsp; Martinus Nijhoff Publishers,
1987;269-84.</p>

<p class=p3>&nbsp;</p>

<p class=p15>11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs CD.&nbsp; Head and
neck cancers.&nbsp; In:&nbsp; Wittes R (ed) <i>Manual of Oncologic
Therapeutics.</i>&nbsp; Philadelphia:&nbsp; J.B. Lippincott Co, 1989;212-22.</p>

<p class=p3>&nbsp;</p>

<p class=p15>12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C.&nbsp; Head and
Neck Cancer.&nbsp; In:&nbsp; Magrath I (ed) <i>New Directions in Cancer
Treatment.</i>&nbsp; Berlin: Springer-Verlag, 1989;455-58.</p>

<p class=p15>&nbsp;</p>

<p class=p15>13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Audeh MW, Jacobs C, Rice
D.&nbsp; Anaplastic carcinoma, lymphoma, and unusual Malignancies, and
chemotherapy for thyroid cancer.&nbsp; In: Falk&nbsp;SA (ed) <i>Thyroid
Disease.</i>&nbsp; New York:&nbsp; Raven Press, 1990;527-535.</p>

<p class=p15>&nbsp;</p>

<p class=p15>14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs CD. Prevention and
management of regional and distant metastasis:&nbsp; Introduction.&nbsp;
In:&nbsp; Fee WE, Goepfert H, Johns MA, Strong EW, Ward PH (eds) <i>Head and
Neck Cancer</i> vol 2. Philadelphia: BC Decker Inc 1990; 239.</p>

<p class=p15>&nbsp;</p>

<p class=p15>15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Haselow RE, Warshaw MG,
Oken MM, Adams GL, Aughey JL, Cooper JS, Schuller DE, Jacobs CD.&nbsp;
Radiation alone versus radiation with weekly low dose cis-platinum in
unresectable cancer of the head and neck.&nbsp; In:&nbsp; Fee WE, Goepfert H,
Johns MZ, Strong EW, Ward PH (eds)&nbsp; <i>Head and Neck Cancer</i> vol 2.
Philadelphia: BC Decker Inc 1990;279-281.</p>

<p class=p15>&nbsp;</p>

<p class=p15>16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs CD, Goffinet DR,
Fee WE Jr.&nbsp; The use of chemotherapy for organ preservation in the
treatment of advanced resectable head and neck cancer.&nbsp; In:&nbsp; Fee WE,
Goepfert H, Johns MA, Strong EW, Ward PH (eds) <i>Head and Neck Cancer</i> vol
2. Philadelphia:&nbsp; BC Decker Inc 1990;295-297.</p>

<p class=p15>&nbsp;</p>

<p class=p15>17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C. Etiologic
considerations for head and neck squamous cancers.&nbsp; In:&nbsp; Jacobs C
(ed) <i>Carcinomas of the Head and Neck.</i>&nbsp; Boston: Kluwer Academic
Publishers 1990;265-282.</p>

<p class=p15>&nbsp;</p>

<p class=p15>18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pinto H, Jacobs CD.&nbsp;
Chemotherapy for recurrent and metastatic head and neck cancer.&nbsp; In:&nbsp;
<i>Hematology/Oncology Clinics of North America</i>.&nbsp; Philadelphia: WB
Saunders Co 1991;667-686.</p>

<p class=p15>&nbsp;</p>

<p class=p15>19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs CD.&nbsp; Head and
neck cancers.&nbsp; In:&nbsp; <i>Manual of Oncologic Therapeutics</i>.&nbsp;
Philadelphia: JB Lippincott 1991;154-160.</p>

<p class=p15>&nbsp;</p>

<p class=p15>20.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Forastiere AA, Jacobs
CD.&nbsp; Biophysiology of antineoplastic chemotherapy for head and neck
cancer.&nbsp; In:&nbsp; Cummings CW (eds) <i>Otolaryngology-Head and Neck
Surgery</i>.&nbsp; St. Louis:Mosby Year Book 1993;116-142.</p>

<p class=p15>&nbsp;</p>

<p class=p15>21.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C.&nbsp; Lymphoma
of the head and neck.&nbsp; In:&nbsp; Bailey BB (ed) <i>Head and Neck Surgery -
Otolaryngology</i>. Philadelphia: J. B. Lippincott Co. 1993;1221-1228.</p>

<p class=p15>&nbsp;</p>

<p class=p15>22.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pinto HA, Jacobs C.&nbsp;
Combined modality treatment of head and neck squamous cancers.&nbsp; In:&nbsp;
Niederhuber JE (ed) <i>Current Therapy in Oncology.</i>&nbsp;
Philadelphia:&nbsp; BC Decker 1993;157-161.</p>

<p class=p15>&nbsp;</p>

<p class=p15>23.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pinto HA, Jacobs C.&nbsp;
Distant metastases from head and neck squamous cancers:&nbsp; The role of
adjuvant chemotherapy.&nbsp; In:&nbsp; Hong WK and Weber RS (eds) <i>Head and
Neck Cancer</i>.&nbsp; Boston:&nbsp; Kluwer Academic Publishers 1995;243-262.</p>

<p class=p15>&nbsp;</p>

<p class=p15>24.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pinto HA, Jacobs C.&nbsp;
Head and neck cancer –– combined modality therapy and chemotherapy.&nbsp;
In:&nbsp; Brian MC and Carbone PP (eds)&nbsp; <i>Current Therapy in
Hematology-Oncology</i>.&nbsp; St. Louis:&nbsp; Mosby 1995;352-358.</p>

<p class=p15>&nbsp;</p>

<p class=p15>25.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C, Pinto HA.&nbsp;
Head and neck cancers.&nbsp; In:&nbsp; Macdonald JS, Haller DG and Mayer RJ
(eds) <i>Manual of Oncologic Therapeutics</i>, 3rd edition.&nbsp;
Philadelphia:&nbsp; J.B. Lippincott 1995; 162-169.</p>

<p class=p15>&nbsp;</p>

<p class=p15>26.<span class=s1><span style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Jacobs C, Yuen A.&nbsp; Lymphomas of the Head and Neck.&nbsp; In:&nbsp;
Bailey BJ (ed) <i>Head and Neck Surgery -- Otolaryngology</i>.&nbsp;
Philadelphia:&nbsp; Lippincott-Raven 1998; 1595-1603.</p>

<p class=p3>&nbsp;</p>

<p class=p15>27.<span class=s1><span style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Yuen A, Jacobs C.&nbsp; Lymphomas of the Head and Neck.&nbsp;
In:&nbsp; Bailey BJ (ed) <i>Head and Neck Surgery – Otolaryngology</i>, Third
Edition.&nbsp; Philadelphia: Lippincott Williams &amp; Wilkins, 2001,
1379-1384.</p>

<p class=p3>&nbsp;</p>

<p class=p15>28.<span class=s1><span style='font-size:7.0pt'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Advani R, Jacobs C.&nbsp; Lymphomas of the Head and Neck.&nbsp;
In Bailey BJ (ed) <i>Head and Neck Surgery – Otolaryngology, </i>Fourth
Edition.&nbsp; (In press)</p>

<p class=p3>&nbsp;</p>

<p class=p15>&nbsp;</p>

<p class=p15><b>PUBLISHED LETTERS &amp;</b> <b>EDITORIALS</b></p>

<p class=p12>&nbsp;</p>

<p class=p12>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C, Donaldson
SS, Rosenberg SA, Kaplan HS.&nbsp; Pregnancy and Hodgkin's disease
(Letter).&nbsp; Ann Intern Med 1982;96:532.</p>

<p class=p12>&nbsp;</p>

<p class=p12>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C, Donaldson
SS, Rosenberg SA, Kaplan HS.&nbsp; Hodgkin's disease and the pregnant patient
(Letter).&nbsp; Ann Intern Med 1982;96:682.</p>

<p class=p12>&nbsp;</p>

<p class=p12>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C.&nbsp;
Systemic therapy of head and neck cancer.&nbsp; A commentary.&nbsp; Oncology
1989;88-97.</p>

<p class=p12>&nbsp;</p>

<p class=p12>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C.
&nbsp;Adjuvant chemotherapy for head and neck cancer.&nbsp; Editorial.&nbsp; J
Clin Oncol 1989;7:823-826.</p>

<p class=p12>&nbsp;</p>

<p class=p12>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C, Sikic B.
Re: Modification of cisplatin toxicity with diethyldithiocarbamate (Letter).</p>

<p class=p12>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; J
Clin Oncol 1991;9(4):706.</p>

<p class=p12>&nbsp;</p>

<p class=p12>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C, Pinto
HA.&nbsp; Head and neck cancer with an occult primary tumor.&nbsp; N Eng J Med
1992;326:58-59.</p>

<p class=p12>&nbsp;</p>

<p class=p12>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jacobs C.&nbsp; Head
and neck cancer in 1994:&nbsp; A change in the standard of care.&nbsp; J Natl
Cancer Inst 1994;86: 250-2.</p>

<p class=p12>&nbsp;</p>

<p class=p12>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Moreno E, Jacobs C,
Nelson M.&nbsp; Medical education journal club (Letter).&nbsp; Acad Med
1995;70(7):562.</p>

<p class=p12>&nbsp;</p>

<p class=p12>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ganjoo KN, Demetri
GD, Jacobs C, Patel S. Acute myeloid leukemia in patients with gastrointestinal
stromal tumors treated with Gleevec. Leuk Lymphoma. 2009 Nov;50(11):1882-4</p>

<p class=p3>&nbsp;</p>

<p class=p20><span style='mso-bidi-font-family:"Times New Roman"'>&nbsp;<o:p></o:p></span></p>

</div>

</body>

</html>
